SCHEMBL7097777

SCHEMBL7097777

CC1(Cc2ccccc2)NC(=O)NC1=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
ADAM17 P78536 4/20 0.50
MMP2 P08253 6/20 0.47
MMP9 P14780 5/20 0.47
MMP13 P45452 4/20 0.47
MMP8 P22894 3/20 0.47
CYP3A4 P08684 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CACNA1F O60840 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
HTR2A P28223 1/20 0.44
HRH1 P35367 1/20 0.44
SCN1A P35498 1/20 0.44
SCN4A P35499 1/20 0.44
BLM P54132 1/20 0.44
PMP22 Q01453 1/20 0.44
CACNA1D Q01668 1/20 0.44
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15972776 1.00 ALDH1A1 (0.60) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL29195204 0.86 ELANE (0.46) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL21379715 0.82 ALDH1A1 (0.43) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL9584263 0.82 SMN1; SMN2 (0.68) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL10131015 0.80 CYP3A4 (0.53) ALDH1A1ADAM17MMP13CYP3A4SMN1; SMN2
SCHEMBL5182781 0.80 ALDH1A1 (0.46) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL5182263 0.80 ALDH1A1 (0.46) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL542639 0.80 SMN1; SMN2 (0.73) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL944078 0.78 ALDH1A1 (0.57) ALDH1A1ADAM17MMP2MMP9MMP13
SCHEMBL940446 0.78 ALDH1A1 (0.57) ALDH1A1ADAM17MMP2MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0037672-B1 PROCESS FOR THE PREPARATION OF CHIRAL HYDANTOINS, AND A NOVEL HYDANTOIN PRODUCED BY SAID PROCESS AND A PHARMACEUTICAL COMPOSITION CONTAINING IT PFIZER INC. (US) 1986-05-14 EP claimed
JP-2276586-A None JP disclosed
JP-2119796-A None JP disclosed
US-11028052-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2021-06-08 US disclosed
EP-3461816-B1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED (US) 2021-03-24 EP disclosed
US-10421727-B2 Compounds useful as modulators of TRPM8 FIRMENICH INCORPORATED (US) 2019-09-24 US disclosed
EP-3461816-A1 FIVE-MEMBERED HETEROCYLIC COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2019-04-03 EP disclosed
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 FIRMENICH INCORPORATED 2017-12-28 US disclosed
US-9840471-B2 Compounds useful as modulators of TRPM8 SENOMYX, INC. (US) 2017-12-12 US disclosed
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. 2015-12-31 US disclosed
EP-2958897-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2015-12-30 EP disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed
EP-0725142-B1 PROCESS FOR PRODUCING D-AMINO ACID BY USING COMPOSITE IMMOBILIZED ENZYME PREPARATION KANEGAFUCHI CHEMICAL IND (JP) 2003-09-10 EP disclosed
US-5552318-A ENANTIOSELECTIVE SYNTHESIS OF D-AMINO ACIDS INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1996-09-03 US disclosed
US-5552317-A POLYMERIZATION OF MONOMERS IN THE PRESENCE OF ENZYME AND HYDROLYSIS INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 1996-09-03 US disclosed
JP-H02276586-A PRODUCTION OF D-HOMOPHENYLALANINE BIO-LE KK 1990-11-13 JP disclosed
JP-H02119796-A PRODUCTION OF L-HOMOPHENYLALANINE BIO-LE KK 1990-05-07 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10421727-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885ADAM17 3914/4885MMP2 4601/4885
US-20150376136-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885ADAM17 3914/4885MMP2 4601/4885
US-20170369447-A1 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885ADAM17 3914/4885MMP2 4601/4885
US-11028052-B2 Compounds useful as modulators of TRPM8 TRPM8, TRPM7, TRPA1 ALDH1A1 1692/4885ADAM17 3914/4885MMP2 4601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.